Skip to main content
Clinical Trials/NCT06244394
NCT06244394
Completed
Not Applicable

A Retrospective Study to Establish a Prediction Model for Radiation-induced Brain Damage in Nasopharyngeal Carcinoma Patients Based on Pretreatment Imaging and Radiotherapy Data

Jiangsu Cancer Institute & Hospital1 site in 1 country230 target enrollmentJune 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nasopharyngeal Carcinoma
Sponsor
Jiangsu Cancer Institute & Hospital
Enrollment
230
Locations
1
Primary Endpoint
NPC patients without RTLI
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Radiation therapy has become the preferred treatment for nasopharyngeal cancer due to the sensitivity of nasopharyngeal carcinoma to radiation. However, even with the use of intensity-modulated radiation therapy (IMRT), radiation-induced temporal lobe injury (RTLI) can be a severe complication. Patients with RTLI may experience long-term memory loss, personality changes, physical dysfunctions, and other symptoms, which seriously impair their quality of life and long-term prognosis. Currently, the diagnosis of RTLI primarily relies on clinical symptoms and imaging examinations such as computed tomography (CT) and conventional MRI. However, these methods only enable the diagnosis of RTLI at a late stage when it is irreversible and cannot be effectively treated. Therefore, the early identification or individualized prediction of RTLI after IMRT holds exceptional importance for improving the quality of life in nasopharyngeal carcinoma patients.

The exact mechanism of RTLI remains unclear. Many clinical covariates have been proven to be associated with RTLI in NPC patients, including stage, age, and dosimetric parameters. In addition, it was reported that each patient's temporal lobe exhibits unique genetic susceptibility to radiation exposure. In this study, we aim to predict the occurrence of RTLI by analyzing clinical factors and heterogeneity of temporal lobe tissue prior to irradiation. Finally, we want to construct and validate a prediction model for RLTI, which can support clinician decision-making in developing individualized treatment plans and providing preventive measures.

Registry
clinicaltrials.gov
Start Date
June 1, 2023
End Date
December 10, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jiangsu Cancer Institute & Hospital
Responsible Party
Principal Investigator
Principal Investigator

Lirong Wu

Associate chiefphysician

Jiangsu Cancer Institute & Hospital

Eligibility Criteria

Inclusion Criteria

  • (1) pathological confirmation of NPC; (2) receipt of IMRT; (3) nasopharynx-neck MRI within 2 weeks before antineoplastic treatment

Exclusion Criteria

  • (1) temporal lobe invasion; (2) with central nervous system diseases except RTLI; (3) receiving additional radiation after IMRT; (4) incomplete clinical or imaging data

Outcomes

Primary Outcomes

NPC patients without RTLI

Time Frame: three years

Patients with nasopharyngeal cancer who were not diagnosed with radiation-induced

NPC patients with RTLI

Time Frame: three years

Patients with nasopharyngeal cancer who were diagnosed with radiation-induced brain injury during follow-up period

Study Sites (1)

Loading locations...

Similar Trials